Citi Lowers Price Target on Phibro Animal Health to $44 Amid Regulatory Pressures
Citi reduced its price target for Phibro Animal Health Corporation (NASDAQ:PAHC) from $62 to $44 in a sector research update, citing regulatory pressures and valuation compression across the industry. The firm maintained a Neutral rating on the stock.
Tickers: $PAHC
Topics: animal_health pharma_stocks sustainability_initiatives